Quick Facts Flashcards

1
Q

Pheo w/up:

A
  1. Spot plasma or urine metanephrine (sensitive)
  2. 24-urine metanephrine (specific)
  3. CT (> MRI)
  4. MIBG (if suspect multi-focal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mucinous cystic neoplasm - dx and tx

A
  • dx: EUS-FNA w/ high CEA (>190), low Amylase
  • tx: resect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tx pelvic fx

A
  1. Binder
  2. Angio OR packing w/ fixation (especially if IR n/a)
  3. Early external fixation
    - refractory bleed after angio → packing + fixation

**MC source is presacral venous plexus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dx and Localize a gastrinoma

A

Dx:
1. Off PPI: G > 1000 or >200 w/ secretin stimlation
2. Can’t get off PPI: SS Scintigraphy

Localize:
1. Triphasic CT/MRI
2. SS Scintography (Dotatate PET/CT)
3. Endoscopic US
4. Selective intra arterial Ca
5. OR: Intra-Op US, transduodenal palpation, duodenotomy, palpate HOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tx pseudocyst/WON

A

Dx: US or CT
- if can’t r/o cystic neoplasm on imaging must get EUS-FNA

Tx: drain if persistent sxs. Wait 4-6 weeks for the wall to mature
- near stomach/duo, > 6cm: endoscopic cystogastrostomy/duodenostomy
- open or lap cysto-enterostomy (usually jejunostomy if not abutting duo or stomach)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tx of pancreatitis masses
1. WON sterile
2. WON infected
3. Pseudocyst
4. Infected pseudocyst

A
  1. WON sterile: conservatively
  2. WON infected: step-up approach
  3. Pseudocyst: tx if sxs (infxn, obstruction, pain)
    - 4-6w → internal drain → cyst-enterostomy
  4. Infected pseudocyst: drainage (internal, external, endoscopic). Endoscopic preferred.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indications to tx ICA stenosis and sxs

A
  1. Asx: > 60%
  2. Sxs: > 50% (>125 cm/s)
    - Sxs: contralateral motor/sensory sxs, ipsi vision sxs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bethesda criteria for thyroid

A

**1 cm is cutoff to get an FNA

  1. Non-diagnostic → repeat FNA
  2. Benign → follow-up
  3. Undetermined significance → repeat FNA or lobectomy
  4. Follicular neoplasm → lobectomy
  5. Suspicious for malignancy → lobectomy vs. thyroidectomy
  6. Malignant → thyroidectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Achalasia - Px, Dx, Path and Tx

A

Px: dysphagia (to solid and liquid) is MC sx

Dx:
- no peristalsis
- high LES pressure > 15 (vs. scleroderma, low)
- incomplete relaxation

Path: injured ganglion cells

Tx: only motility disorder w/ upfront surgery
- myotomy (6 eso, 2 stomch) is 1st line (avoid Nissen).
- botox or dilation if high risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tx Medullary thyroid cancer

A
  1. TOTAL thyroidectomy
  2. > 1 cm or bilobar: bilateral central/level 6 dissection
  3. Lateral neck dissection on that side if central+
  4. Start T4 postop. Monitor w/ calcitonin AND CEA
    - RAI is c/i! (C cell origin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Radial scar- Dx and Tx

A
  1. Dx: aka comlpex sclerosing lesion
    - Mammo: spiculated mass with central sclerosis (lucency) and surrounding distortion
    - Histo: fibroelastic core w/ entrapped ducts
    Gross: white center (central scar)
  2. Tx: core bx ➡ excisional bx (to r/o ca)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tx mucinous neoplasm of the appendix

A
  1. Confined to appendix: appe only (no LADN’y)
    - must have negative margin
    - scope in 6w to r/o sync lesions
  2. Involving base, ruptured, or +margin: R hemi +/- LADN
  3. Peritoneal dissemination: perc bx
    - if appendicitis: remove ruptured segment + directed peritoneal bx
    - no appendicitis: postpone appe until cytoreductive surgery
    - no hipec/cancer operation until staged

**need post-op scope to r/o synchronous lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When to excise burns

A
  • < 72 hours but not until after appropriate fluid resuscitation
  • Used for deep 2nd-, 3rd-, and some 4th-degree burns
  • Viability is based on punctate bleeding (#1), color, and texture after removal (use dermatome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Liver lesions on arterial phase:
HCC
Mets
Adenoma
Hemangioma
FNH

A
  • HCC: rapid enhancement. rapid w/out. “hot” on nuclear imaging
  • Mets: Hypoattenuation
  • Adenoma: rapid enhancement. rapid w/out. “cold” on nuclear imaging. gado/eovist not retained
  • Hemangioma: peripheral nodular enhancement. delay: centripetal fill-in (no early washout!)
  • FNH: Centrifugal enhancing. w/out except for scar enhancement. take up sulfer colloid and gado/eovist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Elective surgery after stent

A
  1. ASA lifelong
  2. Plavix
    - BMS: 1 month
    - DES: 6 months (ideally). Can be 1 month if needed for urgent surgery (cancer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Teg interpretation:
R time
K time
a angle
MA
LY 30

A

R time- FFP
K time- cryo
a angle- cryo
MA- PLTs
LY 30- TXA

Rule of 6’s:
R > 6 minutes
alpha angle > 60 degrees
MA < 60 mm
LY30 > 6%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tx and Survival Benefit of ARDS

A
  • TV at 4-6 ml/kg
  • Permissive hypercapnia
  • Proven benefit: prone, lung protection, paralyze
    -P/F < 100 = severe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Glucagonoma - loc, px, dx, tx

A

Loc: distal (a cells)

Px: dermatitis, DRH, DM, nec mig erythema
- most malignant
- no stones (vs. SS’oma)

Dx: gluc > 1000

Tx: distal panc + splenectomy + LADN’y + CC’y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

z11 trial implications

A
  • If less than 3 nodes positive on SLN and T1 or T2 disease, BCT is OK
  • if >70, t1, ER+ and SNLBx neg ➡ can consider no XRT after lumpectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hard signs of vascular injury

A

shock
expanding hematoma
pulsatile bleed
thrill/bruit
absent pulse
ischemia

If negative ➡ ABI…if positive ➡ CTA (to localize)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Polyps that require surgery instead of endoscopic resection

A
  1. Submucosal invasion > 1mm
  2. Poorly differentiated
  3. <1 mm margin
  4. LV invasion
  5. Tumor budding
  6. Taken piecemeal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

T staging indications for neoadjuvant
- eso
- stomach
- colon
- rectal
- lung

A
  • eso: T2 (MP)
  • stomach: t2 (MP)
  • colon: t4b (adjacent organs)
  • rectal: t3 (through MP)
  • lung: n2 nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Screening in IBD patients

A
  • Start 8 years after sx onset
  • 2-4 random bx every 10 cm throughout the colon + suspicious areas

Repeat schedule:
- normal: q1-3 years
- PSC, stricture, or dysplasia w/out colectomy: q1 year

Any dysplasia usually gets a colectomy
- if resectable can consider endoscopic resection with close surveillance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NEC - px and tx

A

Px: bloody stools after 1st feed
- prematurity is biggest RF

tx:
- resuscitation, ngt, abx (no surgery) x 7-10 day (50% success)
-surgery (50%): resect all non-viable segments. create stoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

W/up of thyroid nodule found on exam or incidental imaging

A
  • U/S and TSH:

a. Nodule + Low TSH ➡ RAI uptake scan
- hot/functioning: toxic adenoma (no cancer) ➡ thionamide, b-block + lobectomy
- cold: FNA

b. Nodule + Normal/High TSH ➡ FNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Tx male breast ca

A

Tx: simple mastectomy w/ SLNBx
- BCT usually can’t be done b/c not enough tissue
- if ER+: tamoxifen (Her2+ is rare). consider orchiectomy if metastatic.
- More likely ER/PR+ than females!
- Prognosis similar to W but delay in px
- a/w BRCA 2/Chromosome 13. Should BRCA test if family hx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

General principles - repair of Bile Duct Injury

A
  1. Intro-op:
    - convert to open, intra-op cholangio, repair OR
    - widely drain and send to specialty center
  2. Post-op:
    - Perc cholangiography to define the anatomy
    - Control spillage: external drain +/- stent +/- PTC
    - Repair in 6-8 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Eso dysplasia tx

A
  1. LGD: ablation OR scope q6-12m
    - OK for fundoplication
  2. HGD: ablation + Q3m scope
    - fundoplication c/i
  3. T1a: ablation
  4. t1b (or low risk T2): upfront esophagectomy

*Fundoplication does not decrease cancer risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Tx hemobilia after trauma

A
  1. EGD → CTA (if stable)
  2. angio embolization (no surgery)
    - catheterize the celiac artery first ➡ R/L hepatic ➡ SMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Indications for chemotherapy for rectal cancer

A
  1. Neoadjuvant:
    Stage 2 and above
  2. Adjuvant chemo as well for Stage 3+ (nodes)

**XRT either pre or post-op (not both)
**Typical course: chemo-XRT ➡ surgery ➡ chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Periop anticoagulation - risks and tx

A

Risks:
- High risk pt: afib, MHV, recent TE event (3m)
- High risk surgery: nsurg, optho, cards

Tx:
- bridge for high-risk patients
- stop warfarin 5 days before surgery if not bridging, resume on day of surgery
- Hold Noac 2 days before surgery and resume 1 day after
- stop Plavix 5 days before
- resume AC within 24h for low risk surgery. 48-72h for high risk surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Margin for invasives cancer vs. dcis

A
  1. Invasive cancer- no tumor on ink
  2. DCIS- 2 mm

**if both in specimen, margin is no tumor on ink

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Neuroblastoma dx and tx

A

dx:
- CT: displacement of renal parenchyma (vs. Wilm’s)
- Can also use MIBG and VMA levels (like pheo)
- Usually adrenal. Can also be neck, chest, spine
- neck can px w/ horner syndrome
- tissue bx to get n-myc status

tx:
1. S1-2 (low risk) → surg alone
2. S3+ or n-myc+ (high risk) → chemo/XRT then XRT
- need bx: chemo regimen determined by n-myc amplification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

TEF - MC types
dx and tx

A
  1. Type C - MC, 85%
    - Proximal esophageal atresia (blind pouch) and distal TE fistula
    - dx: AXR ➡ distended, gas-filled stomach, coiling tube
    - no UGI needed!
  2. Type A: second most common, 5%
    - Esophageal atresia and no fistula
    - dx: XR: gasless abdomen, coiling tube
    - no UGI needed!

Tx:
1. Resuscitate w/ repogle tube
2. Echo: VACTERL cardiac w/up
3. G-tube placement to decompress and feed
4. Delayed RIGHT extra-pleural thoracotomy
5. Distal ligation of TEF (if gas in abdomen, type C)

**long term r/o dysphagia and GERD in almost ALL patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Birads score

A

0- redo imaging
1- negative, NTD
2- benign, NTD
3- benign, repeat q6m
4- suspicious, bx
5- highly suspicious, bx
6- confirmed, excise

**discordance: perform repeat bx w/ surgical excision or core bx (if there was a correctable error)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

PFTs for lung resection

A
  1. Preop FEV1 and DLCO predicted > 80% ➡ no further testing
    - >.8L wedge, >1.5L lobe, >2L pneumo
    - < 80% ➡ lung scan for PPO FEV1, DLCO
  2. PPO FEV1, DLCO > 60% ➡ no further testing
    - < 60% ➡ exercise test
  3. VO2 > 10 ml/min/kg ➡ OK for surgery
    - < 10 ➡ high risk for surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Gastrinoma - loc, px, dx, tx

A

Loc: gastrinoma triangle (CBD, panc neck, 3D)

Px: refractory PUD
- Mostly malignant

Dx: G > 1000 (off PPI) or >200 w/ secretin (off PPI)
- SS Scintigraphy (dotatate scan) if can’t get off PPI
- MRI for regional disease

Tx: Screen for MEN1
- <2 cm: enucleate w/ LADN’y
- > 2cm: resect w/ LADN’y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

W/up of pancreatic cystic neoplasms:
Pseudocyst
Serous cystadenoma
MCN
IPMN

A
  1. MRI
  2. EUS w/ FNA (If unclear):

-Pseudocyst: high Am, low CEA
-Serous cystadenoma: low Am, low CEA
-MCN: low Am, high CEA (>200)
-IPMN: high Am, high CEA (>200)

***High CEA > 190

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Indication for APR

A
  1. Rigid proctoscopy: w/ in 2cm of anal verge (levators)
  2. PE: baseline sphincter dysfxn
  3. Recurrent SqCC (s/p Nigro)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Somatostatinoma - loc, px, dx, tx

A

Loc: head

Px: DM, GALLSTONES (> glucagonoma), steatorrhea, block exo/endo pancreas
- most malignant

Dx: sx’s + high fast SS

Tx: resect + LADN’y + CC’y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

EVAR specs:
- Proximal landing
- Common iliac (distal landing)
- Neck angulation
- External Iliac

A

Proximal landing: > 1.5 cm
- diameter < 3cm

Common iliac (distal landing): > 1 cm
- diameter > 8 mm

Neck angulation < 60 degrees

External Iliac diameter> 7mm

**smoking is stronger RF for AAA
**extensive calc is a c/i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Tx of anal fissure

A
  1. Sitz bath, fiber
  2. topical nifedipine/nitroglycerin
    - nitro causes headache
  3. Surgery (or botox)
    - Good sphincter tone: LATERAL, INTERNAL sphincterotomy
    - Poor tone: botox

**If 2/2 crohn’s dz: optimize medical management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Tx of liver lesions:
1. Hemangioma
2. FNH
3. Adenoma

A
  1. Hemangioma: only if sxatic or KM syndrome
    - enucleate (or resect); angioembo if active bleed
  2. FNH: NTD
  3. Adenoma: resect if < 4cm w/out OCP response or > 4 cm, male, or growing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Dx and Tx congential DPGM hernia

A

-Dx: prenatal dx on US ➡ must confirm with MRI

-Tx:
1. intubate (in delivery room)
- goal O2 > 60, CO2 < 60
2. NGT +/- ECM
3. delay OR when stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Supraceliac aortic control

A
  1. HDUS: Enter lesser sac through gastrohepatic ligament, divide posterior crus of diaphram
  2. Stable: left medial visceral rotation is preferred
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Dx and Tx Phyllodes

A

Bx: stromal overgrowth, atypia, high MI, “leaf-like”
- aggressive fibroepithelial lesion
- non aggressive is fibroadenoma

Tx: WLE w/ 1 cm margin + XRT (if > 5cm)
- can spread hematogenous to lung (more than ax nodes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Indications for total thyroidectomy (pap and follicular)

A

Indications for total thyroidectomy:
- Tumor > 4cm
- Tumor 1-4cm and patient preference
- Distant mets or extra-thyroid disease
- Nodal disease
- Poorly differentiated
- Prior radiation

*micro-mets do not count as distant disease
**if thyroid lobectomy only: tx with thyroid hormone to suppress TSH, get serial U/S to monitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Soft tissue sarcoma - dx and tx

A

dx:
- < 3cm: excisional bx
- > 3 cm: core needle (preferred) or incisional

tx:
- resect w/ 2 cm marg
- neoadj: rhabdomyo, Ewing, high grade, > 10 cm
- adj XRT: > 5cm, high grade, recurrence, close marg
- adj chemo: never

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Step up approach

A

Infected pancreatic necrosis (WBC + gas on CT)

  1. CT with gas
  2. Carbapenem
  3. FNA + Perc drain OR endo drain (if stomach is close to pancreas)
  4. Upsize drain
  5. MIS retrop necrosectomy (VARD)
  6. Open necrosectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Types and Tx SVT

A

types: af, aflutter, paroxysmal SVT, WPW

  1. vagal → adenosine
    - may unmask afib/flutter
  2. HDS: BB, CCB ➡ sync cardioversion
  3. HDUS ➡ sync cardioversion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Melanoma w/up and tx

A
  1. Punch bx or excisional bx (if < 2cm, non-sensitive area)
    - MIS- 5mm margin
    - <1mm- 1cm
    - 1-2mm- 1-2cm
    - >2mm- 2cm
  2. Clinical positive nodes (stage 3) require FNA for confirmation
    - negative: SLNBx
    - positive: completion LN dissection
  3. SLNBx: > 1mm (T2) or if .75-1 mm w/ ulceration or mitotic rate > 1 (T1b)
  4. If SLNBx+ (stage 3): q4m US surveillance OR completion LN dissection
  • LN dissection: superficial 1st. Deep if cloquets+, clinically+ positive, >3+ on SLNBx, or CT+ for deep nodes

**MOHS can be used for in-situ disease. Need 5 mm margin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Steps of rapid sequence intubation

A

c-spine stabilize → preO2 → fentanyl → etomidate → succinylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Px, Dx and Tx malrotation

A

Px: bilious emesis

Dx: UGI duodenum does not cross midline
- should be done in all infants with bilious emesis

Tx: urgent OR (risk of malro)
1. resect Ladd’s bands
2. widen the mesentery (resect central bands)
3. counterclockwise rotation
4. place cecum in LLQ (cecopexy), duodenum in RUQ
5. appendectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

MEN syndromes

A

1- pancreatic (gastrin), pituitary (prolactin), parathyroid (PTH); menin; AD

2a- Parathyroid (PTC),MTC, Pheo (catecholamines); ret; AD

2b- Pheo, MTC, marfanoid/neuroma; ret; AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

lower extremity bypass graft failure depends on temporal relation to the surgery.

A
  • <30d: technical error
  • 1m-2y: intimal hyperplasia, (at the distal anastomosis)
  • > 2y: progressive atherosclerotic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Dx and Tx Parathyroid ca

A

Dx: palpable neck mass + Ca > 14 is presumptive dx. Otherwise, dx intra-op based on gross features.
- FNA is not recommended
- Treat based on intra-operative gross invasion. Frozen section is not helpful.

Tx:
1. Control hypercalcemia: usually > 14
- IV fluids 1st! Then bisphosphonates
- cinacalcet (sensipar - ca mimetic)

  1. Parathyroidectomy w/ hemithyroidectomy (+/- L6/central neck dissection +/- XRT)
    - no chemo
    - usually don’t perform any node dissection unless palpable nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Mechanism and Tx of thyroid dz:
1. Graves
2. TMN
3. Hashimoto’s
4. DeQuervains/Subacute
5. Reidels

A
  1. Graves: IgG stimulates TSHr ➡ hyperT
    - BB, PTU, RAI ➡ thyroidectomy
  2. TMN: chronic TSH stimulation ➡ hyperT
    - BB, PTU, RAI ➡ total/subtotal thyroidectomy
  3. Hashimoto’s: antiTPO/TG Ab ➡ hypoT
    - thyroxine ➡ partial thyroidectomy
  4. DeQuervains/Subacute: viral URI
    - path: giant cells, leukocytes
    - NSAIDS/ASA ➡ steroids
  5. Reidels: autoimmune inflammation
    - steroid, thyroxine ➡ surgery for compression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Sonograph FNA recs

A
  • cystic: no bx

-isoech/hyperech: FNA if > 2cm

-hypoech (high sus): FNA if > 1cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Triple therapy

A

PP1 + 2 antibiotics abxs: amoxicillin, metronidazole, tetracycline, clarithromycin for 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Gail model

A
  1. age
  2. age 1st period (earlier is worse)
  3. age 1st birth (earlier is better)
  4. 1d relative
  5. previous bx
  6. race
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

types of endoleak and tx

A
  1. proximal/distal seal: immediate balloon expansion of distal/proximal attachments + stent
    - 1a: proximal leak
    - 1b: distal leak
  2. back bleeding: observe. coil embolization if enlarging
  3. graft defect (tear or junctional leak): immediate additional graft coverage
  4. porosity- reverse anticoagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Carcinoid vs. GIST vs. Desmoid- cells and tx

A
  1. Carcinoid- Kulchinsky cells (enterochromaffin-like)
    tx- < 2cm ➡ appendectomy; > 2cm ➡ R hemi/oncologic resection; chemo if unresectable
  2. GIST- cajal cells
    tx- resection (MC stomach), imantinib
  3. Desmoid- spindle cells
    tx- resect if extra-abdominal. NSAID/estrogen if intra
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Hyperaldosterone w/up

A

Px: resistant HTN and hypokalemia

  1. AM plasma aldo/renin
    - A/R < 20: 2nd hyperaldo
    - A/R > 20: primary hyperaldo ➡
  2. Confirmatory test: salt load suppression test
    - give salt load ➡ 24h urine aldo remains elevated
  3. Discern laterality: CT scan! (>MRI)
    A. Unilateral: lap adrenal (consider adrenal vein sampling 1st if > 35 to r/o BAH)

B. Bilateral or negative ➡ adrenal vein sampling
- Lateralization: lap adrenal
- No lateralization: idiopathic hyperplasia ➡ tx medically

**tx HTN with spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Dx and Tx of SBP

A

dx: ↑ascitic PMN ANC > 250 (Se) and
- don’t require culture (Sp)
- e. coli is MC (usually single organism)

tx:
1. paracentesis for cx
2. abxs:
- <48h/community acquired: 3GC
- >48h/hospital acquired: carbapenem + MRSA coverge (dapto)
3. Albumin (survival benefit)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Tx acute variceal HMHG

A
  1. Resuscitate, ensure airway
  2. Octreotide + antibiotics
  3. Endoscopic intervention (ligation/sclerotherapy)
  4. Blakemore
  5. TIPS (temporized with Blakemore)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Tx SVC syndrome tx

A
  1. Elevate HOB
  2. Chest CT with IV contrast (can skip CXR)
  3. Consider bronch
  4. Assess sxs
    A. Life-threatening sxs: secure airway ➡ consider AC (if thrombus) ➡ venogram ➡ endovascular stenting
    B. Mild sxs ➡ tissue bx ➡ decide on XRT/chemo
    - no chemo/XRT unless its 2/2 cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Tx appendicitis

A
  1. Uncomplicated: lap appe
  2. Septic/Unstable: immediate lap appe
  3. Stable w/ abscess
    - < 3cm: lap appe
    - > 3cm: IR drain ➡ interval appe, offer scope
  4. Crohn’s ileitis
    - intra-op with normal appendix AND cecum ➡ appe to r/o dx uncertainty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Tx MEN2A/B

A
  1. urine metanephrine to r/o pheo 1st
  2. tx pheo 1st w/ adrenalectomy
  3. Address thyroid
    - 2A: total thyroid + bilateral central neck by 5y
    - 2B: total thyroid + bilateral central neck by 1y
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Tx MEN1

A
  1. HyperPTH 1st w/ 4-gland resection (hyperplasia not adenoma) + thymectomy (remove ectopics)
  2. Asses other lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Prog and Tx anaplastic thyroid ca

A

Prognosis:
- aggressive, undiff
- mort ~ 100%; no tx

Tx: XRT improves short-term survival +/- surg
- BRAF inhibitor for chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Criteria for transanal excision of adenocarcinoma

A
  1. T0 or T1 (submucosa)
  2. < 3 cm
  3. < 30% circumference
  4. Palpable on DRE (<8cm from anal verge)
  5. No high-risk features (poorly diff, LV invasion)

**local recurrence rate is higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

HNPCC screening and treatment

A

CRC: scope q1-2y starting at 20-25
- Surgery if:CRC or endoscopically unresectable lesions
- TAC with IRA w/ q1y rectum surveillance
- endometrial/ovarian cancer screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Dx and Tx choledochal cyst

A

Dx: U/S or HIDA

Tx:
1. fusiform dilation: REY-HJ
2. diverticulum: simple excision
3. choledococele: transduo excision vs. sphincteroplasty
4a. intra + extra dilation: hepatic resection + recon
4b. extra only: excision + recon
5. intra only: transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Px, Dx, and Tx:

Duo atresia
TEF
Pyloric stenosis
Intussusception
Malro

A

Duo atresia: newborn; bilious emesis directly after birth
- a/w down syndrome
-dx: AXR- double bubble with no gas distally. don’t need UGI
-tx: duodenoduodenostomy

TEF: newborn, spit ups. can’t place NG. resp sxs
- dx: AXR- gasless (A), gas (C)
- tx: right extra-pleural thoracotomy

Pyloric stenosis: 1-3 months; NB projectile vomiting
-dx: U/S- 4mm thick, 14 mm long. String sign on UGI
-tx: pyloromyotomy (1-2 from duo to antrum)

Intussusception: 3m-3y; currant jelly stool
- dx: U/S w/ bull’s eye
- tx: air contrast enema

Malro: 1y-5y; sudden onset bilious emesis
- dx; UGI- no duo sweep (any child w/ bilious emesis)
- tx: ladd’s procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Tx of GB cancer

A

1a: LC only
- lap chole only
- excise to negative CD margin
1b: muscle involved
- OPEN chole + seg 4b and 5 + portal LADN
- CD margin positive: REY-HJ

**high suspicion for GB Ca should also get an open chole (polyp > 2cm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Tx of CBD stone intra-operatively

A
  1. Flush ➡ glucagon x 2
  2. Lap exploration
    A. Transcystic: stone < 1 cm, <8 stones, no CHD stones
    B. Lap CBD: stone > 1cm, > 8 stones, CHD or junction stones
  3. Open exploration: if lap exploration failed
    - CBD < 2 cm: trans-duo sphincteroplasty
    - multiple stones, CBD > 2 cm: biliary-enteric drainage.
    - Leave T-tube

**thin CD can be dilated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

W/up Hurthle Cell Cancer

A
  1. FNA- hurthle cells (can be seen in other conditions)
  2. Lobectomy 1st for diagnosis
  3. If malig: total thyroidectomy +/- L6 nodes
  4. If palpable nodes: MRND

No RAI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Hernia repairs:
Bassini
McVay
Lichtenstein
Shouldice

A

Bassini: conjoint tendon to inguinal ligament (from pubic tubercle medially to internal ring laterally)
- may need relaxing incision in anterior rectus sheath

McVay: open the floor to ➡ conjoint tendon to cooper’s/pectineal ligament.
- transitional stitch from conjoint, cooper’s, and femoral sheath at medial aspect of femoral vein
- re-approximate the rest of the inguinal floor by suturing the conjoint tendon to the inguinal ligament
- may need relaxing incision

Lichtenstein: mesh to inguinal ligament and conjoint tenown

Shouldice: divide the floor ➡ 4-layer tissue closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Tx for cholangiocarcinoma

A

Tx:
1. Resectable if:
- contralateral hemi-liver with intact HA, PV, and biliary drainage with no tumor
- no distant mets or organ invasion

  1. Consider location
    - Upper ⅓ (Klatskin): lobectomy and stenting of contra lobe
    - Middle ⅓: hepaticojejunostomy
    - Lower ⅓: Whipple
  2. Chemo + transplant if unresectable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

IPMN - dx and tx

A

dx: MRI 1st! then EUS/FNA; high CEA, high amylase
tx:
1. Branched
- resect if >3 cm, sxs, or signs of malig (nodule)
- Otherwise surveillance
2. Main duct
- resect if > 1 cm or sxs (60% chance of Ca)
- 5-9 mm EUS/FNA. Resect if SOMalig
- < 5mm, surveillance MRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Path, Dx and Tx of Zenkers

A

Path: outpouching SUPERIOR to cricopharyngeous

Dx: UGI (don’t do EGD) ➡ manometry (r/o dysmotility)

Tx: open or scope approach:

<2cm : myotomy alone
>2cm: multiple options
- consider endoscopic stapling +/- myotomy
- 2-5 cm: myotomy with suspension or inversion
- larger: diverticulectomy with myotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

VIPoma - loc, px, dx, tx

A

Loc: distal

Px: watery DRH- hypoK, met acid. achlorhydria, inhibits gastrin
- DRH ➡ bicarb sexn ➡ met acid
- most malignant

Dx: high VIP

Tx: distal panc + splenectomy + LADN’y + CC’y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Gastric CA tx - chemo, margins, nodes

A
  • neo-adj chemo for T2+ or N
  • proximal- total gastrectomy
  • distal- partial
  • 5 cm margin; 15 nodes
  • Can consider endoscopic mucosal resection: if < 2cm, well-differentiated, mucoa only, no LV invasion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Milan criteria

A

indications for trx w/ HCC
- Single tumor < 5cm
- No more than 3 tumors each < 3 cm

**Hepatectomy if compensated cirrhosis (no portal HTN), low MELD, and solitary mass < 3 cm is still preferred

**5-year transplant pt survival is 65-90%

indications for trx of cholangioca
- cant be intrahepatic
- must be unresectable, perihilar, < 3cm
- no distant mets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Insulinoma - loc, px, dx, tx

A

Loc: throughout (B cells)

Px: whipple’s triad. Most benign.

Dx: I/G > .4 and high C-pep
- dx w/ fasting test 1st!
- endoscopic U/S most sensitive for detection

Tx: < 2cm encucleate, >2cm resect.
- High carb diet 1st
- Diazoxide if can’t tolerate surgery
- LADN’y if suspect malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Specific to Crohn’s and UC

A
  1. Crohn’s:
    - Creeping fat
    - Skip lesions
    - Transmural
    - Cobblestoning
    - Granulomas
    - Fistulas
  2. UC:
    - Crypt abscess
    - Pseudopolyps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Gastric ulcers: elective classification and management

A

Dx- EGD and Bx (Bx needed to r/o ca!)
Tx-only tx if refractory to max medical management after 12 weeks.

  1. lesser curve/antrum; normal acid ➡ distal gastrectomy w/ bil 2
  2. gastric + duo; high acid ➡ antrectomy + vagotomy
  3. pre pyloric: high acid ➡ antrectomy + vagotomy
  4. GE junction: normal acid ➡ sub-total gastrectomy + REY
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Emergent vs. Elective UC Tx

A

Emergent:
1. Steroids +/- abxs
2. Infliximab, Cyclosporine
3. No response, megacolon (> 6 cm), HDUS, or perf ➡ TAC with end-ileostomy
- When stabilized can perform proctectomy and IPAA
- Don’t do proctectomy in emergent situations

Elective:
- Indications: dysplasia, cancer, refractory disease
- PC w/ IPAA

** Surgery reduces: erythema nodosum, arthritis
– no effect on PSC or ank spondy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Zone injuries and management

A
  1. penetrating:
    - zone 1-3 ➡ explore
  2. blunt:
    - zone1 ➡ explore
    - zone 2-3 ➡ do not explore
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

FAP - Dx and Tx

A

Dx: > 100 adenoma or < 100 w/ fam hx
- AD; APC mutation
- CA by 40
- desmoid tumors (slow growing abdominal wall mass)

Tx:
- sigmoidoscopy q1y at 10 (don’t need colonoscopy)
- EGD @ 20 or when polyps start- SB polyposis
- TAC w/ IRA or PC w/ IPAA depending on rectal involvement at about 20 (or once florid polyposis is seen)
- q1y EGD post op for duodenal cancer (MC COD after colectomy)
- q1y c’scope if TAC
- polyposis/high grade dysplasia @ stump → proctectomy +/- pouch
- desmoid: resect. Anti-E if intra-abdominal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

BRCA risks and tx

A

female breast, ovarian, male breast
I (ch17)- 60, 40, 1
II (ch13)- 60, 10, 10

Tx:
-pre-meno: offer bilateral mastectomy OR q1 MRI starting @ 25
- @ 30 annual MRI w/ mammo
-post meno: bilateral mastectomy + SOO + HRT until 50 (no TAH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

When to operate on adrenal mass

A
  1. all functioning tumors
  2. all > 6 cm ➡ open resection
  3. if < 6cm with suspicious features - >10HU, <50% @ 10m w/out ➡ open resection

**DO NOT biopsy first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Adjuvent chemo for breast ca

A
  1. Adjuvent chemo: tumor > 1cm, nodal dz, triple neg
    - echo before for cardiotox
  2. Tamoxifen/Anastrazole: 5y for HR+ tumors
    - Tamox for men
  3. Trastuzumab- 1y for Her2/neu+ tumors
    - echo before for cardiotox
  4. Olaparib- 1 year for triple negative/BRCA+ tumors
    - PARP inhibitor

**Oncotype recurrence score > 26 requires adjuvant chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

FNH - path, dx and tx

A

path- CENTRAL STELLATE SCAR!
dx- bright on arterial phase homogenous
tx- resect if sxatic. no malignant potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Pancreas drainage procedures

A
  1. duct > 7mm- Peustow, pancreaticojej (for large duct)
  2. duct > 7mm and large head- Frey, pancreasticojej + core out head
  3. duct < 7mm and large head- Berger, pancreatic head resection
96
Q

Tx papillary/follicar thyroid cancer

A
  1. Indications for total thyroidectomy:
    - Tumor > 4cm
    - Distant mets or extra-thyroid disease
    - Poorly differentiated
    - Prior radiation
  2. Nodes dissection:
    A. Lateral neck dissection: of involved compartments if palpable or bx+ nodes
    B. Prophylactic neck dissection (level 6): if > 4cm, extra-thyroid invasion, +lateral nodes.
    - Usually not performed for follicular
  3. Radio iodine indications (6w post op, want TSH high)
    - Only after total thyroidectomy to be effective
    - For high risk tumors: tumor > 1 cm, extra-thyroidal disease
97
Q

Screening guidelines for breast ca

A

Mammogram every 2–3 years after age 40
then yearly after 50

High-risk screening
- mammogram 10 years before the youngest age of diagnosis of breast CA in first-degree relative

98
Q

LN harvest/margin
eso
stomach
colon
rectum

A

eso- 15/7cm
stomach- 15/5cm
colon-12/5 cm
rectum- 12/5 cm

99
Q

Tx acute limb ischemia

A

Tx: Rutherford

1: no deficits ➡ hep gtt. imaging. eventual revasc

2a: motor intact ➡ imaging. hep gtt (motor intact, sensation). eventual revasc
- if early post-op case skip the imaging

2b: any weakness, rest pain ➡ hep gtt and immediate revasc (don’t image if delay in tx)
- if present in prior graft perform thrombectomy

3: paralysis ➡ amputation

Revasc options:
1. Endovascular: short segment, single lesion
2. Open: long segment, multiple lesions

100
Q

Hemangioma - path, px, and tx

A

path- PERIPHERAL ENHANCEMENT with continued late filling

px- young women

tx- if rupture, size change, or KM syndrome

101
Q

Chylothorax dx and tx

A
  1. dx: fluid TG > 110
  2. tx: chest tube and NPO
    - < 1L/day: MCT diet, octreotide, TPN → 7d: thoracic duct lig (Open R chest or IR)
    - > 1L/day: thoracic duct ligation (Open R chest or IR)

**for cancer patients: pleurodesis > ligation

102
Q

Tumor lysis syndrome - px, path and tx

A

Px: Common 2/2 B cell lymphoma
- hyperU, K, Ph w/ hypoCa

Path: CaPh crystal ➡ renal failure + hypoCa

tx: IV hydration ➡ iHD

103
Q

Dx and Tx of GIST

A
  1. Dx: MC GI Sarcoma
    - EGD + FNA: SM smooth EGD mass with normal overlying mucosa and central ulcer. Stomach MC.
    - Bx: cajal cells. c-KIT+
    - don’t require bx if high suspicion
  2. Tx: wedge resection (gross margin)
    - can be R0 or R1 resection
    - Imatinib (TK inhibitor) ➡ 5cm or >5 mitosis/50 hpf
    - mitosis/hpf is most predictive of prognosis (>mets)
    - neoadjuvant if need to down-stage for resection
    - adjuvant for 3 years
104
Q

Benign lesions that require excisional bx

A

Core needle returns ➡
- Atypical (25% of malignancy)
- DH/LH
- LCIS/DCIS
- radial scar
- papillary lesion
- any atypia

**lesions generally have a 15-30% chance of carcinoma in situ or invasive cancer

105
Q

Future Liver Remnant requirements and indications for PVE

A
  1. minimum 20% if normal liver
  2. pre-op chemo/some dysfxn = 30%
  3. cirrhosis = 40%

-Otherwise should undergo PVE
-Overt PH is a c/i to PVE

106
Q

hepatic adenoma - imaging, tx, and risks

A

path- EARLY enhancement on arterial phase w/ rapid washout. well-circumscribed.
**vs hemangioma: peripheral enhancement over time

tx- stop OCP use.
resect immediately if > 5cm, sxatic, male gender

risks:
1. rupture MC
2. malig transformation

107
Q

Types of mastectomy

A
  1. Simple/Total mastectomy: removal of all breast tissue, NAC, most of skin (no nodes)
  2. MRM: removal of breast parenchyma, NAC, skin, AND level 1-2 nodes
  3. BCT: partial mastectomy + XRT
108
Q

Barrett’s eso surveillance (progress to cancer)

A

Bx: Goblet cells and columnar cells

  1. No dysplasia: 4 quad every 2 cm q 3-5y
  2. LGD: 4 quad every 1 cm q6m. Consider ablation.
  3. HGD: ablation/endoscopic resection. 4 quad every 1 cm q3m

*Fundoplication is only c/i in HGD

109
Q

RF, Dx and Tx SqCC of anal canal

A

RF: HPV 16/18, STI, HIV
- test for cervical ca too

Dx:
- Anoscopy + FNA/core bx
- HIV test all patients

Tx:
- Nigro protocol: XRT (ing/pelvic nodes) + 5FU + MitoC
- Recurrence (10-20%): q6 months to diagnose ➡ APR
- Lateral to I/S groove (anal margin): tx like skin cancer

110
Q

Treatment of colo-cutaenous fistula

A
  1. Start with conservative tx
  2. Quantify output:
    - High output: > 500 cc/day ➡ likely OR. Start with NPO/TPN.
    - Low output: < 200 cc/day ➡ likely conservative. OK for PO intake.
  3. If input increased with PO intake ➡ NPO and TPN
  4. OR if failed after about 6 weeks
111
Q

T staging for esophageal cancer

A

t1a: muscularis mucosa: endo resection

t1b: SM: upfront esophagectomy (or low grade t2)

t2: muscularis propria: neoadjuvant
- low risk: upfront esophagectomy

t3: adventitia: neoadjuvant
*no serosa. Ca spread through SM lymphatics

112
Q

Grading and tx of BCVI

A

1- <25% narrowing ➡ ASA
2- > 25% narrowing ➡ ASA
3- PsA ➡ ASA + IR stent
4- complete occlusion ➡ ASA only
5- transection ➡ OR if accessible. Otherwise IR.

*most are not surgically accessible

113
Q

Ectopic parathyroids

A
  1. Superior parathyroids: from 4th pouch
    - usual location: posterior to RLN.
    - Not found: explore retro-esophogeal and para-esophogeal space ➡ open carotid sheath.
    - TE groove is MC ectopic location
  2. Inferior parathyroids: from 3rd pouch (with thymus)
    - usual location: anterior to RLN.
    - Not found: explore thymus and thyroid ➡ consider thymectomy or ipsi thyroidectomy even if no palpable mass
    - thyrothymic ligament is MC ectopic location
    - more commonly ectopic b/c longer travel
  3. 4 normal appearing galnds
    - supranumary PT in the thymus

**Overall, thymus is MC location or ectopic gland

114
Q

Trauma to the pancreas

A
  1. Head
    - main duct: drain + post-op ERCP + staged resection
    - no duct: drain
  2. Tail
    - main duct (grade 3+): resect w/ splenectomy (unless CHILD and HDS)
    - no duct (grade 1-2): drain
115
Q

DCIS mammo and tx

A

Mammo: clustered calcs

Tx: like ca
- BCT: lumpectomy (2mm) + XRT +/- boost +/- endocrine
- no SLNBx (does not metastesize)
- no chemotherapy
- if XRT c/i → mastectomy AND SLNBx (b/c 20% have invasive ca)

116
Q

DCIS SLNBx

A
  • does not metastasize
  • not w/ l’omy unless >4cm, multicentric, palpable, high grade
  • required w/ mastectomy b/c 20% have invasive ca
117
Q

Post polypectomy screening

A

-2-6m: piecemeal removal

-1 year: > 10 adenomas

-3 years: 3+ adenomas, HGD, > 1cm, villous elements

-5 years: 1-2 tubular adenomas (< 1cm)

-10 years: hyperplastic polyps (<20)

118
Q

Dx and Tx of Meckels

A

dx: suspect if recurrent intususpeption, GI bleeds
- Meckel’s scan (Tc-99) is best test. Increase Se by giving pentagastrin, glucagon, h2 blocker. Not as Se in adults (atrophic gastric cells)
- only detects gastric tissue (not panc)
- if negative but high suspicion ➡ repeat scan
- if inconclusive then proceed with abdominal exploration (not CT)

tx: resection if sxs
- base < 2 cm → diverticulectomy
- > 2 cm or wide base → seg resection
- appendectomy as well if exploratory surgery for presumed appe ended up being meckels
- If incidental: resect meckel’s in kids, leave in adults.

119
Q

Ureter injuries

A
  1. proximal ⅓ (U/P jxn and above) → primary uretero-urostomy.
    Other options: ileal transposition, nephrostomy
  2. middle ⅓ → primary u-u (preferred)
    - Other options: tran uretero-urosotomy, Boari flap
  3. lower ⅓ (distal to iliacs) → re-implanation +/- hitch
  4. early: w/in 5 days- stent, explore, or repair
    - HDUS intra-op: ligate, perc neph, delayed repair (3m)
  5. late: > 10 days- perc nephro and delayed repair (3m)
120
Q

Tx papillary/follicar thyroid ca

A

Start with lobectomy

Indications for total thyroidectomy:
- Tumor > 4 cm (1-4 cm, close observation or total)
- Extra-thyroidal disease
- Multi-centric or bilateral lesions
- Previous XRT

Consider ppx level 6 for high risk

If thyroid lobectomy only:
- Tx with thyroid hormone to suppress TSH
- Get serial U/S to monitor

Indications for MRND
- extra thyroid extension

Radio iodine indications (6w post op, want TSH high)
- Consider for 1-4 cm, definitely > 4cm
- Extra-thyroidal disease
- Need total thyroidectomy to be effective

121
Q

Intraductal papilloma dx and tx

A

dx: dx mammo 1st ➡ U/S is enough or contrast ductogram
- MCCO bloody nipple dc
- only use ductogram if all other imaging is equivocal

tx: excisional biopsy including the ductal segment
- do central duct excision if can’t ID the duct

122
Q

Tx Umbo and Inguinal hernia in child

A

most close by 2
<3cm- primary repair
>3cm- mesh
repair by 5

Inguinal- repair by 2 weeks if reducible
- otherwise, OR then

123
Q

Esophageal CA tx

A
  1. HGD, TIS, T1a: endoscopic ablation/resection
  2. T1b: upfront esophagectomy or endo ablation (if low risk)
  3. T2 or N: neoadjuvant then esophagectomy
    - Low grade T2 (< 3cm, no L/V invasion, well diff): upfront eso
  4. T4b or M: definitive chemo-XRT

< 5cm from cricoP: definitive chemo-XRT
> 5 cm from cricoP: esophagectomy

124
Q

Indications and C/I to anti-reflux surgery

A

Indications:
1. Extra-eso complications: cough, aspiration, CP
2. Persistant sxs
3. C/I to antireflux meds
4. Barrett’s w/out HGD
5. Strictures
6. Esophagitis

C/I:
1. Cancer
2. Barrett’s w/ HGD

125
Q

Classic and Alarm sxs for GERD

A

Classic sxs: heart burn + regurg

Alarm:
1. dysphagia (not regurgitation)
2. odynophagia (pain)
3. bleeding
4. weight loss
5. anemia
*Require EGD

126
Q

Caustic injury w/up

A
  1. Avoid NGT. No neutralizing agents
  2. CT scan if stable
  3. Early endoscopy (AFTER CT)
  4. OR if unstable. Otherwise, restart orals in 48h.

*alkali- liquefaction necrosis. worse outcome
*acid- coagulation necrosis

127
Q

Dx and Tx of Eso perf

A

Dx: XR then contrast esophogography (GG then Ba)
- EGD if UGI is negative but still high suspicious
- don’t require CT

Tx-
1. abxs (fungus)
2. Cervical: open neck and place drains
3. Thoracic: L thoracotomy, extended myotomy, cover w/ 2 layers
- if achalsia: contra myotomy
4. Buttress with IC muscle
NG, chest tube
5. Very unstable: exclusion and diversion

Selective non-op:
1. Contained perf w/ minimal signs of sepsis
OR
2. Very poor operative candidate

Stenting: contained perf or minimal extrav after EGD

128
Q

Refeeding Syndrome - mech and px

A
  • Mech: fat to carb metabolism ➡ resumption of ATP production and Insulin surg ➡ Ph influx into cells ➡ hypoPh
  • Px: HypoMg, Ph, K; paresthesia, confusions, RD
  • COD is cardiac failure
129
Q

Pregnant lap appe

A

Left lateral decubitus position
Entry port:
- take into account fundal height (6cm above)
- P/S @ 12 wks, half-way @ 16 weeks, umbo @ 20 weeks
- 2T-3T: supra-umbo if possible otherwise LUQ or RUQ

130
Q

Segmental liver anatomy

A

7 - 8 - 4a - 2
6 - 5 - 4b - 3

131
Q

W/up of pancreatic cancer

A
  1. Pancreatic protocol CT
  2. EUS: if questionable LN or vessel involvement
  3. ERCP: if jaundice or dx uncertainty
    - 90% sensitive for dx
  4. PET/CT: selectively if suspicion for malignancy.
  5. Staging scope: if suspect disseminated dz
    - > 3cm, high Ca 19-9, tail tumor, high weight loss/malnutrition
  6. Bx: Not if resectable. Only if neo-adj chemo
132
Q

Dx and Tx of chronic mesenteric ischemia

A
  • Dx:
    1. duplex (Celiac > 200, SMA > 275) is 1st line for screening
    2. CTA (>70%) for definitive dx (best test)
  • Tx: Sxs + stenosis of > 70%
    1. Endovascular plasty/stent is 1st line. 1V SMA stenting is enough even if both celiac/SMA are inovlved
    2. Open surgery: if can’t tolerate endovascular
  • aorto-mesenteric/celiac bypass graft vs. endarterectomy vs. mesenteric re-implantation
133
Q

Tx of air embolism

A
  1. LEFT lateral decubitus and Trendelenburg (trap air in the RV)
  2. Aspirate central line
134
Q

Exposure of LE arteries:
1. Femoral
2. AK Pop
3. BK Pop
4. TP Trunk

A
  1. Femoral: vertical incision over the artery from inguinal ligament
  2. AK Pop: frog-leg position. 10 cm MEDIAL incision along groove between Sartorius and vastus medialis. I
  3. BK Pop: frog-leg position. MEDIAL incision below the tibia (along the GSV). Dissect to the deep compartment.
    4, TP trunk: MEDIAL incision below the tibia. Divide soleus origin of the tibia
135
Q

Preference for peripheral fistula

A

Location:
1. Rad/Ceph
2. Rad/Bas
3. Bra/Ceph
4. Bra/Bas
5. Prosthetic peripheral
6. Prosthetic ax-brachial
7. Prosthetic femoral

**Upper extremity preferred to LE

Rule of 6’s:
- flow > 600ml/min
- diameter > 3mm before placement. > 6mm after placement
- depth of 6mm

**artery at least 2 mm

136
Q

SC Steal syndrome - path and tx

A

Path- Prox SC stenosis. Reversal of flow through ipsilateral vertebral to SC

Tx: if V/B sxs (diplopia, vertigo, dysphagia, ataxia)
1. PTA w/ stent to SC artery
2. Carotid to SC bypass

137
Q

Tx of type B dissection

A
  1. Uncomplicated: b-blocker for impulse control, elective repair
    - Surveillance q3, 6, 12m. TEVAR if progression
  2. Complicated: impending rupture, propagation, expansion, malperfusion of aortic branch, refractory pain, refractory HTN ➡ TEVAR
    - Need at least 2 cm landing zone distal to L SC
138
Q

Surgical indications for acid reduction surgery

A

Elective indications:
- refractory to medical management
- suspicion of a malignancy within an ulcer

Acute indications: HDS, minimal contamination AND:
1. PUD w/ unknown h. pylori status (if known can just be tx medically) OR
2. Unable to stop NSAID therapy (NSAID ulcer)

139
Q

Acute surgical options for duodenal ulcer disease

A

Indications: bleeding, perforation, obstruction

  1. Bleeding: EGD ➡ EGD ➡ duodenotomy/gastrotomy w/ over-sewing of ulcer bed
    - can tie off the GDA if continues to bleed
    - no vagotomy
  2. Perforation: get h pylori status! ➡ omental patch w/ post op h. pylori treatment (90% H.pylori related)
    - If close to pylorus: pyloroplasty (+/- truncal vagotomy)
    - If giant ulcer (> 2 cm): controlled duodenostomy, jejunal or omental graft/patch, partial gastrectomy
  • Only do acid surgery acutely (vagotomy/drainage) if:
    1. HDS, minimal contamination AND
    2. PUD w /h. pylori status negative, unknown, refractory OR unable to stop NSAID therapy (NSAID ulcer)

**EGD does not require bx for duodenal ulcers

140
Q

Tx of gastric ulcer disease

A

Indications for surgery: bleeding, perforation, refractory
- 8-12w of PPI + H. pylori eradication
- must bx at 8 spots

Approach:
1. GC, antrum, body: wedge resection
2. Lesser curve: distal gastrectomy w/ bili
3. GEJ:
- bleeding: anterior gastrotomy, over-sew, send biopsy
- perf: sub-total gastrectomy w/ REY reconstruction

**Can’t wedge lesser curve b/c prominent L gastric arcade and deformed stomach

141
Q

Tx of Complications after Billroth 2:
- Afferent limb obstruction
- Dumping syndrome
- Alk reflux
- Post-vag DRH

A
  1. Afferent limb obstruction: prevent with afferent limb < 20 cm
    - acute: convert Bil 1 or REY (STAT!)
    - chronic: Bacterial overgrowth: try abxs 1st (Rifaximin)
    . convert to REY
  2. Dumping syndrome: small meals, no sugar ➡ octreotide
  3. Alkaline reflux gastritis: prevent w/ roux limb > 40 cm.
    - pro-kinetics, bile-acid binding ➡ convert to REY with long roux
  4. Post vagotomy DRH: cholestyramine (dx of exclusion) ➡ reversed jejunal segment
142
Q

How to confirm H. pylori eradication

A

4-weeks after triple therapy:

  1. Urea breath test: preferred 1st line
  2. EGD + Bx: preferred if known gastric ulcer (r/o CA)
  3. Fecal Ag test

**Gram-, spiral-shaped

143
Q

Removal of perc chole tube

A
  1. Remain in place for 3-6 weeks for tract to form
  2. Cholangiogram to assess CD patency
  3. Clamp tube or elective chole if surgical candidate
144
Q

BSC vs. SqCC - dx and tx

A

BSC: most common malignancy in USA; pearly, rolled borders, peripheral palisading; MC upper lip ca

SqCC : scaly patch; keratin pearls, parakeratosis, full-thickness pleomorphism (partial = AK); MC lower lip ca
- MC ca after trx

Tx:
- 4 mm for unaggressive: well differentiated and < 2 cm
- 8 mm for aggressive: poorly differentiated, > 2cm, or Marjolin
- 1 mm for MOHS
- MOHS for aggressive subtypes
- LADN’y for clinical positive nodes
- Can consider SLNBx for high risk SqCC
- Limited role for chemo/XRT

145
Q

Dx and Tx of Nec Fac

A

Dx:
- LRINEC score: Na. glucose, WBC, CRP, Hb, Cr; >8 = 95% PPV
- CT: gas, thick fascia

Bacteria profile:
- MC polymicrobial
-if monomicrobial, MC GAS/strep pyogenes: M protein virulence

Tx:
- abxs: carbapenem OR broad spectrum w/ clinda (anti-toxin effect) and MRSA coverage
- surgery

146
Q

Types of hyperPTH

A

1- High Ca/Low Ph: over-secretion

2- Low Ca/High Ph: CKD or VitD def (physiologic)

3- High Ca/High Ph: hyperplasia 2/2 kidney transplant

**VitD def: compensatory hyperPTH 2/2 to low Ca and Ph

147
Q

RF and Tx of T/I fistua

A

RF- trach below 4th ring OR, high pressure cuff, high innominate cross

  1. Over-inflate the cuff
  2. Intubate from above
  3. Compress against the sternum
  4. Median sternotomy
  5. Ligation AND division of innominate artery
  6. Buttress tracheal hole w/ muscle

**aorto-enteric fistula should also be treated aggressively with operative takedown and extra-anatomic bypass

148
Q

Px, dx and tx Lymphocele

A

Px: sudden decrease in UOP weeks after trx
-2/2 lymphatic leak from iliac dissection
-Sirolimus is a RF

Dx: US

Tx: perc drain (if sxs) ➡ peritoneal window

149
Q

w/up of kidney graft dysfunction

A
  1. Elevated Cr. Low UOP.
  2. US: high RI is a non-specific finding
    - Vascular abnormality ➡ angio, stent, or surg
    - Lymphocele/Urinoma ➡ perc drain ➡ perit window
    - Negative: graft dysfunction ➡ Core needle bx
150
Q

Dx and Tx of LCIS

A

Dx
- usually incidental/bilateral
- pre-menopausal white women. mammo negative
-R/o breast ca is .5% per year

Tx
- Lumpectomy/Excisional bx (10-20% chance of DCIS/CA)
- Don’t need negative margins
- No SLNBx
- Can use tamoxifen to prevent hormone+ cancers (even if you don’t know hormone status)

PPx options
- Surgery
- Hormonal therapy
- Surveillance w/ MRI or mammo q6m

151
Q

Dx and Tx of inflammatory breast ca

A

Dx: clinical diagnosis
- rapid erythema with paeu de orange < 6 months
- mammo/US first!: must have path of invasive cancer
- bx: dermal lymphatic invasion is suggestive but not required

Tx:
1. Neo-adjuvant
- can give trastuzumab if HER2+
2. MRM
3. XRT
4. Endocrine tx

152
Q

Fibroadenoma - px, dx, tx

A

Px: painful/larger w/ periods or pregnancy

Dx:
- imaging: well-circumcribed, coarse ca+
- bx: fibro-epithileal lesions (“aggressive” = phyllodes)

Tx:
- obesrve if: mobile, concordant imaging/bx
- resect if: > 3cm, sxs, growth, anxiety, discordance, lesions “not further defined”

153
Q

Tx of breast ca in preg

A

Dx: mammo + U/S + bx
- mammo is safe

Tx:
1T (13w): mastectomy + SLNBx (radioactive sulfer) +/- chemo at 2T

2-3T: lumpectomy + SLNBx (radioactive sulfer) +/- chemo + post delivery XRT
- chemo is safe in 2nd/3rd trimesters. XRT is not
- XRT is c/i throughout preg

**No blue dye!

154
Q

Indications for post-mastectomy radiation

A
  1. > 5cm (T3+)
  2. 4+ nodes (N2)
  3. margin positive
  4. skin involvement
  5. inflammatory BC

**if prefer recon must be delayed or used a tissue expander for immediate recon

155
Q

Access to neck zones

A

Zone 1: thoracic inlet to cric ➡ median sternotomy with left neck incision

Zone 2: cric to angle of mand ➡ left neck incision

Zone 3: angle of mand to skull base ➡ IR

156
Q

Px and W/up of Hypercortisolism (Cushing’s syndrome)

A

px: moon facies, striae

  1. Initial tests: choose 1-2
    - 24h urine free cortisol (most se)
    - late night salivary cortisol (when cortisol is lowest)
    - overnight 1 mg dexa suppression
  2. ACT Level
    A. ACTH normal/high - high dose dexa suppresion
    - no suppression: small cell lung ca
    - suppressed: pituitary adenoma (Cushing’s disease) (MC endogenous)

B. ACTH low
- CT positive: adrenal mass
- CT negative: exogenous (most common)

157
Q

Dx, Path and Px, and Tx of carcinoid tumors

A

Dx: neuroendocrine tumor
- 24H urine HIAA
- chromoA for progression (not specific, false + on PPI)
- Octreotide scan if can’t locate

Path: +chormogranin. desmoplastic mesentery.
- grade ~ Ki67 index

Px:
- Rectum > SI (ileum) > Appendix (MC tumor of appendix)
- GI tract > pulm > GU. Rectum MC
- Carcinoid Syndrome: 2/2 liver mets or large GI tumor

Tx:
- SS analogues (lanreotide) for sxs
- < 2 cm: local excision (transanal, appendectomy, segmental) ➡ no further w/up.
- > 2 cm: staging CT. formal cancer resection.
- all lung carcinoids get formal resection with MLND
- c/scope post-op b/c 15% have synch lesions

158
Q

W/up of Hashimoto’s disease

A
  1. FNA- r/o ca
  2. Bloodwork- antiTPO/TG Ab
  3. Tx- thyroxine ➡ partial thyroid

**MCCO hypoT and goiter in the US

159
Q

Standard w/up for lung ca

A
  1. PET/CT
  2. PFTs
  3. Bronchoscopy (can be intra-op)
  4. Mediastinal eval- EBUS or mediastinoscopy
160
Q

Pressor for neurogenic shock

A
  1. Above T6: nor-epi (b/c HoTN and brady)
  2. Below T6: Phenylephrine (may worsen brady above T6)

**don’t normally get neuorgenic shock below T6

161
Q

Subclavien exposures

A
  1. Median sternotomy: right
  2. Left Anterolateral thoracotomy: left subclavian
    - trap door supraclav incision for distal access
162
Q

Indications for hepatectomy instead of liver trx in HCC patient who meets Milan criteria

A

Compensated cirrhosis, no portal HTN, low MELD, and solitary mass < 3 cm
- hepatectomy is preferred to transplant if they are Childs A

163
Q

Desmoid Tumor - associations, path and tx

A

A/w:
- FAP (after surgery, 2nd MCCO death), Gardner syndrome

Path: non calcified, fibrotic, low mit index, spindle cells

Tx:
- WLE for extra-abd; NSAID, anti-Estrogen (tamoxifen) if intra!
- XRT if sensitive area

164
Q

Serologic work-up for adrenocortical mass

A
  1. Dexa suppression (cortisol)
  2. Urine androgens (sex hormones)
  3. Plasma metanephrines (pheo)
  4. aldo/rennin ratio > 30 (salts)
165
Q

Respectability of pancreatic tumor and next step

A

Triple phase CT:

  1. Unresectable- distant met, >180 SMA/celiac, any aorta/IVC, unreconstructable PV/SMV
    - EUS/FNA for tissue dx for neoadjuvant
  2. Borderline- <180 SMA/celiac, reconstructable PV/SMV
    - EUS/FNA for tissue dx for neoadjuvant
  3. Resectable
    - dx lap (to confirm resectability) + whipple
166
Q

Tx of horseshoe abscess

A

Hanley procedure:
- Midline drainage incision of deep posterior space (through ano-coccygeal ligament)
- Bilateral lateral counter-incisions for ischiorectal space
**all external drainage

167
Q

Tx of anorectal fistula

A

<30% sphincter- fistulotomy or cutting seton
>30% sphincter- draining setons THEN ARAF or LIFT

**Crohns patient: px w/ multiple fistulas
- avoid fistolotomy.
- draining setons.
Can try infliximab if active infection has resolved.

168
Q

Tx of Internal HMHDs

A

G1- bleeding, G2- spontaneous reduce, G3- manual reduce:

1st line: sitz, stool softener, bowel reg, fiber, fluids
2nd line (office): band, sclerotherapy, coagulation
- band is most effective
- sclerotherapy if on blood thinners

G4- can’t reduce
- surgical HMHD’ectomy (stapled has higher recurrence)

169
Q

Tx of External HMHDS

A

1st line: sitz, stool softener, bowel reg, fiber, fluids
2nd line: surgical HMHD’ectomy
Thrombosed: incise or excision if w/in 48h

170
Q

Unresectable cholangiocarcinoma

A

Criteria
- bilateral HA or PV
- unilateral HA with extensive contra duct
Tx
- no extrahepatic dz ➡ neoadj chemo-XRT + liver trx
- extrahepatic dz ➡ chemo-XRT

171
Q

Lap CBD exploration

A
  1. Dissect CD to the level of the duo
  2. Cholodochotomy distal to the CD/CBD junction
  3. Fush, basket, or fogarty balloon the stone out
  4. Close primarily, over a T-tube, or over a stent
172
Q

Px and Tx of Chalangitis

A

Dx: fever, RUQ, and jaundice
- stones > malignancy > stricture
Tx:
- signs of sepsis: resuscitate/abx then urgent ERCP
- no sick: US/MRCP

173
Q

Tx strategy for CBD transections

A
  1. Intra-op
    - <50%, not cautery: primary repair
    - >50%, or cautery: REY-HJ
  2. Late phase
    - Place drain
    - Define anatomy w/ ERCP, PTC, or MRCP
    - Place PTC tube
    - CTA to assess for R/L HA injury
    - Delayed reconstruction 6-8 weeks once optimized
174
Q

Management of GB polyps

A
  1. Sx: cc’ectomy
  2. For asx:
    - > 18 mm: tx as GB cancer
    - > 10 mm: CC’y
    - 6-10 mm: q6m U/S for 1 year. cc’ectomy if PSC
175
Q

Dx and Tx of Colovesicular Fistula

A
  1. CT w/ oral/rectal (no IV b/c will obscure bladder)
    (not cystoscopy, colonoscopy, or Ba enema)
  2. Colonoscopy to r/o malignancy
  3. Cystoscopy if suspect cancer. Retrograde cysto if CT is equivocal or operative planning

Tx- resect sigmoid even if asx; Don’t need to repair the bladder, just drain

176
Q

Colon cancer and arterial resection

A
  1. R hemi- IC, RC, RBMC
    - cecum/asc colon
  2. Extended R- IC, RC, MC
    - hepatic flex/prox t colon
  3. L hemi- LBMC, LC
    - Distal TV, splenic flex, prox descending
  4. Extended L- LBMC, origin of IMA
    - splenic flex
  5. Sigmoid- IMA (hi- b4 LC, low- after LC)
    - dist desc/sig
177
Q

Colon CA surveillance after curative resection

A
  1. Exam and CEA q3-6m x 3 years
  2. Colonoscopy @ q1, 3, and 5 years
    - No prior scopes: q3-6m (intra-op scope is difficult in un-prepped bowel)
  3. CT CAP q1y x 3 years
  • At 2 years: recurrence local or hepatic
  • after 2 years: hepatic more often
178
Q

Staging w/up of rectal cancer

A
  1. TRUS (avoid if > t2) or MRI- T/N stage
    - suspicious nodes on MRI count as clinical stage N (neo-adj)
  2. CT CAP- M stage
  3. C’Scope- for initial dx and sync lesion. not for T stage
  4. Rigid Sig’Scope- for distance from anal verge (required! even. if c’scope done)
179
Q

Tx of Lynch Syndrome

A
  1. CRC: MC
    - q1y C-scope @ 20-25
    - TAC w/ IRA or TPC w/ IPAA if CA or unresectable adenoma
    - q1y scope post op
  2. Endometrial: 2nd MC
    - q1y endometrial sampling @ 30-35
    - ppx TAH-BSO after children
  3. Ovarian:
    - q1y TVUS and Ca-125 @ 30-35
    - ppx TAH-BSO after children
  4. Stomach:
    - EGD/Bx q2-3y @ 30-35
  5. Renal: transitional cell ca
    - q1y UA and US @ 30-35
180
Q

APR vs. LAR

A

Tumors that require APR:
1. < 5cm for anal verge
2. Tumor at dentate line w/ sphincter involved
3. Tumor that can’t get a 1 cm distal margin w/out sphincter
4. Poor pre-surgical anorectal function (history of DRH)
5. Locally recurrent low-lying cancer

**Generally follows pre-chemo location of tumor unless COMPLETE tumor response. If tumor initially involved the sphincter complex and now does not ➡ still require APR

181
Q

Indications for colonic stent

A
  1. Bridge to surgery in acute obstruction (usually with metastatic cancer)
  2. Palliative measure
    * Usually for L-sided lesions
182
Q

Tx of C. diff

A

Tx:
1. Primary: oral fidox
- oral vanc is 2nd line now

  1. Fulminant: oral vanco w/ IV flagyl; +vanc enema if ileus
    - no fidox
  2. Recurrence: PO fidox or vanco
  3. Multiple recurrence: tapered fidox or vanco
    - consider fecal transplant
  4. Sepsis/Megacolon: total colectomy (colon > 6 cm, cecum > 10 cm)
183
Q

Dx and Tx of ischemic colitis

A

Dx- CT first to rule out non-ischemic colitis or infarction; C’scope to confirm
- suspect in low flow state, HoTN
- CTA can’t dx b/c its a microvascular disease
Tx- usually supportive; OR if perf, sepsis

184
Q

Dx and Sx of PNETs
1. Glucagonoma
2. Inuslinoma
3. Gastrinoma
4. VIPoma
5. SSoma

A

**All require bichemical testing before imaging!

  1. Glucagonoma: glucagon > 1k; NME, DM, DVT (no stones vs. SS’oma)
  2. Inuslinoma: fasting I/G > .4 and high C-pep; whipple triad
  3. Gastrinoma: G > 1k or increase G w/ sec; refractory PUD, HyperCa 2/2 MEN1
  4. VIPoma: high fasting VIP (exclude other causes); DRH, Achlorhydria, hypoK (2/2 DRH)
  5. SSoma: High fasting SS; DM, STONES, steatorrhea

*Do not perform imaging or go to the OR until biochemical diagnosis!

185
Q

Dx and Tx of Pancreatic cysts:
1. Serous cystadenoma
2. MCN
3. IPMN
4. Psuedocyst

A

-W/up: MRI/MRCP or PP CT ➡ >1.5 cm, sxs, dilated main duct, solid component, fam hx ➡ EUS/FNA
1. Serous cystadenoma: low M/CEA, low Am; resect if sxs
2. MCN: high M/CEA, low Am; resect
3. IPMN: high M/CEA, high Am; resect if main duct or > 3 cm
4. Pseudocyst: low M/CEA, high Am; observe x 6w; if sxs or > 6cm cystgastrostomy

186
Q

Tx of PNETs:
1. Glucagonoma
2. Inuslinoma
3. Gastrinoma
4. VIPoma
5. SSoma
6. Non functional

A
  1. Glucagonoma: distal panc w/ splenectomy + cc’y
  2. Inuslinoma: enucleate
  3. Gastrinoma: enucleate if < 2 cm; >2 cm, whipple
  4. VIPoma: distal panc w/ splenectomy + cc’y
  5. SSoma: resect w/ cc’y
  6. Non functional: < 2cm observe or enucleate. > 2cm resect
187
Q

Px, Dx and Tx of Bacterial Overgrowth

A
  • px: 2/2 bill2 or REYGB
  • watery stools, bloating, b12 deficiency
  • dx: d-Xylose (carb test breath test)
  • tx: abxs (Rifaximin) ➡ surg 2nd line
188
Q

Treatment of lung ca

A
  1. No N2 disease (stage 1-2) ➡ up-front surgery
    - lobectomy + MLNDx. Can consider segmentectomy.
    - can wedge if 2:1 margin ratio
  2. N2 disease or T4 ➡ chemo-XRT first

n1- ipsi bronchial/hilar nodes
n2- ipsi mediatinal/subcarinal (2-9)
lobe

189
Q

Lung ca w/up

A
  1. < 8mm ➡ surveillance
  2. > 8 mm ➡ PET-CT
    - FDG- ➡ surveillance
  3. FDG+ ➡ tissue dx (either intra-op frozen or CT-guided, bronchoscopy)
    - nodal disease –> EBUS
  4. No N2 dz –> Segmentectomy or lobectomy
    - n2 disease –> chemo
190
Q

Pre-op and intra-op regiments for aldosteronoma and pheo

A
  1. Aldosteronoma: Spironolactone + ACEi/ARB +/- CCB +/- K sparing diuretic
  2. Pheo: phenoxybenzamine then BB

Intra-op:
- HTN crisis: Nitro gtt
- Tachy arrythmia: Esmolol gtt

191
Q

Tx of HCC

A
  1. Solitary nodule, confided to the liver, < 5 cm (not strict), child A, no portal HTN, and adequate liver remnant
    - Consider portal vein embolization if remnant is insufficient
    - Consider pre-op TACE to as an adjunct
  2. Un-resectable disease: child B+, > 5cm (not strict), portal HTN, inadequate liver remnant
    - Transplant if candidate: UNOS criteria
    - Otherwise: loco-regional therapy or systemic therapy
192
Q

When to re-implant the IMA in EVAR

A
  1. Back-pressure < 40
  2. Previous colon surgery
  3. SMA stenosis
  4. Inadequate left colon flow
193
Q

Lynch vs FAP Screening

A
  1. FAP- chromosomal; APC
    - > 100 polyps, including small bowel (duodenum)
    - Surveillance: start at 10
  2. HNPCC (Lynch)- microsatalite; MSH, MLH, PMS, EPCAM
    - <10 polyps in the colon
    - Surveillance: start at 20
194
Q

Surgical Tx of thyroid/PT cancers
1. Papillary/Follicular
2. MTC
3. Hurthle
4. Anaplastic
5. PT

A
  1. Papillary/Follicular: lobectomy +/- total + consider ppx L6 for high risk
  2. MTC: total + bilateral L6 (usually) + T3 post op
    - RAI is c/i
  3. Hurthle: lobectomy then total + bilateral L6
  4. Anaplastic: chemo-XRT +/- total if operable + central and lateral nodes
  5. PT: hemi-thyroid +/- L6 (usually not)

**MRND if L6 is positive

195
Q

Confirmation of brain death

A
  1. Neuro exam:
    - absent brain stem reflexes
    - no response to stimuli
  2. Apnea test: CO2 > 60 after 10 minutes
    - if test aborted OR CO < 60 ➡
    - can’t perform test if confounding factors: unstable, hypercarbia, intoxication, paralytics (unable to wean), c-spine injury
  3. Confirmatory test: CTA, MRA or nuclear scan
196
Q

W/up of UGI bleed/perf:
1. Boerhave
2. Traumatic esophogeal perf
2. UGI bleed

A
  1. Boerhave: XR suggestive ➡ UGI (CT controversial)
  2. Traumatic esophogeal perf: Trauma CT ➡ EGD or UGI
  3. UGI bleed: +/- NGT ➡ EGD
197
Q

px, dx, and tx of meconium ileus

A

px- failure to pass meconium
dx- sweat chloride test, “soap bubble sign” on XR
tx- GG then NAC enemas
- surgery: ostomy for antegrade enema

**Cystic fibrosis is 2nd MCCO pancreatic insufficiency (after chronic pancreatitis)

198
Q

Nutrition requirements per day
1. Protein
2. Fat
3. Carb

A

Nutritional requirements for average healthy adult male (70 kg)

  1. 20% protein calories: 1 g protein/kg/day
    - burn: 1g/kg/day + 3 g/day x % BURN…(usually 2-2.5g/kg/day)
  2. 30% fat calories
  3. 50% carbohydrate calories
199
Q

Afferent limb syndrome - cause, px, dx, tx

A
  1. Cause: affarent limb is too long from LOTz
  2. Px: acute or chronic
    - Acute: complete obstruction requiring emergent OR
    - Chronic: partial obstruction w/ bacterial overgrowth
    - steatorrhea, B12 deficiency. MC w/ antecolic Bili2
  3. Dx:
    - Acute: abdominal pain with dilated afferent limb in early post op
    - Chronic: d-xylose breath test
  4. Tx
    - stat OR for REY revision
    - Chronic: abxs –> REY/shorten the limb
200
Q

Medical tx for melanoma

A
  • Pd1 inhibitors: pembrozilumab, nivolumab
  • CTLA inhibitors: ipilmumab
  • If Braf+: braf inhibitor remains 2nd line
201
Q

Polypectomy criteria that require formal resection

A
  1. Poor differentiation
  2. Vascular/Lymphatic invasion
  3. Invasion below the SM
  4. < 2mm of surgical margin
  5. Base involvement (Haggit 4)
202
Q

Perforated diverticulitis tx

A

Primary anastomosis with DLI (DIVERTI trial) or without DLI (LADIES trial) is safe except if:
- HDUS
- Acidosis
- Acute/Chronic organ failure
- I/S
- Very old
- Poor pre-op sphincter function

203
Q

Indication and s/e for TIPS

A

2-3 paracentesis/month despite Na restriction and diuretics

s/e:
- increase r/o encephalopathy
- no change in overall survival

204
Q

Tx of MCN

A
  • Dx: EUS/FNA ➡ high CEA, low amylase
  • Location: body/tail
  • Spleen Preserving Distal Pancreatectomy (usually can be spleen preserving)
  • No follow-up is needed (no increase r/o recurrence)
205
Q

In transit melanoma tx

A

Lesions > 2cm from primary but not beyond regional tumor basin
- immunotherapy or BRAF inhibitor
- only excise if feasible (few lesions)

206
Q

Px, Mech, Tx of Malignant Hyperthermia

A

px: AD; ryanodine receptor type 1

mech: huge increase in INTRAcell Ca

tx: stop drug, dantrolene, Bicarb, cooling, tylenol
- dantrolene: ryanodine rec antagonist

207
Q

Breast cancer endocrine chemo: MOA, tx duration/indications, s/e:
1. Tamoxifen
2. Anastrazole
3. Trastuzumab

A
  1. Tamoxifen: ER partial agonist
    - for ER/PR positive and < 70
    - 5 years
    - s/e: dvt, endometrial ca
  2. Anastrazole: reversible aromatase inhibitor
    - for ER/PR positive and > 70
    - 5 years
    - s/e: MSK fractures
  3. Trastuzumab: monoclonal Ab to Her2/Neu rec
    - for HER2 positive
    - 2 years
    - s/e: cardiotoxic
208
Q

Paget’s disease of the breast

A

px: scaly, ulcerated crust of the areola

dx: nipple punch bx with epidermal cells w/ clear cytoplasm and oval nuclei

tx: total mastectomy (including NAC) and SLNBx
- don’t need ax dissection
- no breast conservation
- total mastectomy even if small underlying lesion

209
Q

Indications for emergent C-section in preggo trauma

A
  • Within 4 minutes of CPR for cardiac arrest
  • Fetus must be at least 24 weeks
  • Give O, Rh negative blood if needed
  • usually 2/2 abruption (vaginal bleeding)
210
Q

Tx of blunt cardiac injury

A
  1. EKG +/- trop
    - negative: can dc
    - positive: admit to tele (Sinus tach is abnormal)
  2. Persistant arrhythmia or HoTN ➡ echo
211
Q

Dx and Tx of rectal injuries

A

Dx: CT w/ rectal contrast is best

Tx:
1. Intraperitoneal ➡ colonic injury
2. Extraperitoneal ➡ primary repair w/ loop sig colostomy
- if inaccessible just leave open and divert
- avoid presacral drainage or distal washout

212
Q

Px and Tx of Steal syndrome vs. IMN

A
  1. Steal: pain, diminished pulse, cold hand
    - Tx: DRIL (distal revasc interval ligation)
    - Ligate immediately artery side AVF. Bypass distal to the ligation site w/ PTFE
    - 2/2 to impaired compensatory mechanisms
  2. IMN: pain, normal pulse, warm hand
    - Tx: immediate ligation
    - 2/2 nerve ischemia
213
Q

Tx of superficial venous thrombosis

A

Thrombus is in GSV, SSV

  1. AND w/in 3 cm of Saph-fem jxn or saph-pop jxn ➡ therapeutic AC for 3-6 months
  2. No near the jxns ➡ prophylactic AC for 45 days
  3. Otherwise: surveillance

**Superficial femoral vein is a DEEP vein
**EHIT: heat induced thrombus after RFA
- tx with AC until resolution if it involves femoral jxn and > 50% occlusion
- < 50%: compress, NSAID, surveillance

214
Q

Tx of varicose veins

A
  • RFA or EVLA are 1st line
  • Indications for surgery instead: high ligation and vein stripping:
    1. proximal/dilated and tortuous GSV
    2. previous thrombophlebitis
    3. vein too large (RFA > 15mm, EVLA > 8 mm)
  • lower extremity telangiectasias, reticular veins, and small varicose veins ➡ sclerotherapy recommended
215
Q

Tx of perforated colon ca

A
  • HDS: perform a cancer resection
  • HDUS: resect and divert
  • Scope in 3-6 months to r/o synch lesion

**Divert if unstable, contaminated, poor nutrition, etc.

216
Q

Tx and prognosticators of hepatoblastoma

A
  1. neoadjuvant 1st unless pure fetal histology and low mitotix index
  2. resection
  3. transplant if 4+ section involved/unresectable after chemo

Good prog: < 5 yo, AFP > 100

217
Q

VACTERL defects

A

Vertebral
Anal
Cardiac
TE fistula
Renal, Radial bone
Limb defects

218
Q

Biliary atresia - px, dx, and tx

A

px: infant with bilirubinemia

dx:
0. Rule out TORCH infections/neonatal hepatitis
1. HIDA with no contrast in the duo
2. Cholangiogram: look at what segments are strictured
3. perc bx (tissue dx)

tx: REY-HJ vs. REY-portoenterostomy (Kasai) ➡ transplant if unsuccessful

219
Q

Tx of dysplasia with IBD (UC and Crohn’s)

A
  • Screening scopes 8 years after onset. Scope q1-3 years thereafter.
  • Invisible HGD: confirm w/ high-def endoscopy q3-6m ➡ total proctocolectomy w/ IPAA
  • Visible HGD:
    1. Resectable: endoscopic resection + serial scopes
    2. Not-resectable: TC w/ IPAA
  • for Crohn’s can do segmental resection
220
Q

Short gut syndrome - risk/length + feeds

A
  • Adults risk starts at < 180 cm
  • Infants risk starts at < 75 cm
  • Feeds with elemental nutrition
221
Q

Tx of toxic megacolon

A
  • suspect when colon > 6cm
  • TAC w/ end ileostomy
  • Keep the ileocolic intact for future J pouch
  • Keep the SRA intact for good staple line flow
  • Divide rectum above the posterior peritoneal reflection at level of sacral promontory
222
Q

Repair of bile duct injuries based on Strasburg class

A

A- CD stump leak:
- Intraop: clip/ligate and leave drain
- Postop: perc drain + ERCP plasty/stent

B- Aberrant right hepatic ligation:
- Only if sxs ➡ REYHJ

C- Transect aberrant right hepatic:
- Only if sxs ➡ REYHJ

D- Lateral injury to CHD/CBD:
- No devascularization and small: 1’ T-tube closure
- Devascularized: REY-HJ

E- full transection of CHD/CBD
- < 1cm or distal w/out tension: 1’ T-tube closure
- > 1cm OR proximal injury: REY-HJ

e1- > 2cm, below confluence
e2- <2cm, below confluence
e3- at confluence (confluence intact)
e4- at confluence (confluence separated)
e5- aberrant RH duct injury w/ CBD stricture

223
Q

Indications for MRM

A
  1. Prior radiation
  2. Radiation therapy contraindicated by pregnancy
  3. Inflammatory breast cancer
  4. Diffuse suspicious or malignant-appearing microcalcifications
  5. Widespread disease that is multicentric
  6. A positive pathologic margin after repeat re-excision

MRM = removal of breast parenchyma, NAC, skin, AND level 1-2 nodes

224
Q

Px and w/up of cholangioca

A
  1. Px: painless jaundice.
  2. W/up:
    - Ca 19-9
    - CT/MRI
    - Tissue:
  3. ERCP w/ stent: brushings + in 50% (preferred if obstuctive)
  4. EUS/FNA: negative bx does NOT rule out
225
Q

Emergent management of lower GI bleed of unknown origin

A
  • If patient is hypotensive - TAC w/ end ileostomy
  • If stabilized- prep 1st with 4-6L of PEG. Scope w/in 24h.
226
Q

Haggit stage and management

A

Stage: extent of submucosal invasion!
0- superficial to MM (no SM)
1- invasion into head
2- invasion into neck
3- invasion into stalk
4- in SM. superficial to MP.

**all superficial. toMP

Mx:
- all sessile are 4 by definition
- 4 is an indication for resection
- < 4 cancer without high risk features ➡ polypectomy alone w/ follow-up scope in 3 months

227
Q

NCCM CRC screening

A
  • average risk: start at 45. Screen q 10 years.
    -1d relative: start at 40 OR 10y b4. Screen q5 years even if normal.
228
Q

Dx and Tx of contained esophageal perforation

A

dx: gg swallow then thin barium
tx:
- NPO, IV abxs
- consider stenting
- generally don’t need IR drain
- includes cervical and thoracic

229
Q

Tx of Barrett’s

A
  1. PPI or H2 block daily x 8 weeks
    - BID if severe sxs, HGD, or esophagitis
  2. Work-up for anti-reflux surgery
    - dysplasia should be eradicated prior to surgery
  3. Continue surveillance
    - no dysplasia: q5y
    - LGD: q6m. ablation.
    - HGD: q3m. ablation or endoscopic resection.
230
Q

Indications for deep inguinal LN dissection for melanoma and operative considerations

A
  1. > 4 nodes on superficial dissection
  2. Positive cloquet’s node
  3. Enlarged ileo-obturator nodes on CT
  4. Clinically palpable femoral nodes
231
Q

Absolute c/i to BCT

A
  1. Pregnancy
  2. Diffuse micro-calcs
  3. Positive pathologic margin
  4. Multi-quadrant disease
232
Q

Dx and Tx of pediatric Intussusception

A

Dx: U/S, current jelly stools, abdominal mass

Tx:
1. Air contrast enema (75% effective)
- surgery if unstable, perforation, mass, or completely unsuccessful on repeat U/S
2. Repeat enema
3. Observe for 4 hours if success
- only 5% recur

233
Q

Causes of thyrotoxicosis on RAI and tx

A

Low tsh —> thyroid scint

  • diffuse uptake ➡ Grave’s: BB, PTU, RAI ➡ total/subtotal thyroidectomy if refractory (consider lugol’s solution before surgery)
  • focal uptake ➡ toxic adenoma: BB, PTU and lobectomy
  • multiple areas of increased uptake ➡ TMN ➡ RAI and/or PTU ➡ total/subtotal thyroidectomy if refractory
234
Q

Management of penetrating cardiac injury

A
  1. FAST+, HDS ➡ OR for pericardial window ➡ extend to median sternotomy if blood found
  2. FAST+, HDUS ➡ immediate median sternotomy (preferred) or ED thoracotomy (left anterolateral)
    - Finger compression
    - If failure ➡ pledgeted repair (avoid balloon/staples if possible). Horizontal mattress, permanent (prolene)
235
Q

Surviving Sepsis 1-hour bundle

A
  1. Measure lactate
  2. Blood cx b4 abxs
  3. Abxs after cx
  4. 30 ml/cc bolus if HoTN, LA
  5. Pressors for MAP >65
236
Q

Tx of atypical ductal hyperplasia (ADH)

A
  • Get diagnostic mammo
  • Then excisional bx (15-30% of cancer)
  • Like LCIS you do not need a negative margin
  • Finally chemo-ppx with tamoxifen

**ALH and LCIS if low risk and concordant